Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Although elevated activity of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) has been proposed to mediate comorbid depression in inflammatory disorders, its causative role has never been tested. We report that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests. Blockade of IDO activation either indirectly with the anti-inflammatory tetracycline derivative minocycline, that attenuates LPS-induced expression of proinflammatory cytokines, or directly with the IDO antagonist 1-methyltryptophan (1-MT), prevents development of depressive-like behavior. Both minocycline and 1-MT normalize the kynurenine/tryptophan ratio in the plasma and brain of LPS-treated mice without changing the LPS-induced increase in turnover of brain serotonin. Administration of L-kynurenine, a metabolite of tryptophan that is generated by IDO, to naive mice dose dependently induces depressive-like behavior. These results implicate IDO as a critical molecular mediator of inflammation-induced depressive-like behavior, probably through the catabolism of tryptophan along the kynurenine pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“depressive-like behaviors in rodents are mediated by an enzyme that degrades tryptophan, called indoleamine 2,3dioxygenase (IDO; O'Connor et al., 2009; see also Maes et al., 2011)”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as O'Connor et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies have shown that inflammation promotes a pattern of behavior known as sickness behavior that includes symptoms of depression, such as fatigue, anhedonia, and social withdrawal.[10,11]”
From SUICIDAL IDEATION IS ASSOCIATED WITH ELEVATED INFLAMMATION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: Research Article: Suicidal Ideation and Inflammation (2013) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, blocking glutamate receptors with ketamine or inhibiting IDO activity protects mice from LPS- or stress-induced depressive-like behaviour but leaves the inflammatory response intact85,86.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“In preclinical models, LPS-induced depressive behavior is mediated by IDO activation (O’Connor et al., 2009).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as O’Connor et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Self-citationPrevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V., Li, M., Sarang, S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,067
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999
Self-citation
Cited by
Items 201–300 of 1,001
Moranis, A., Delpech, J.-C., Smedt, V. D., Aubert, A., Guesnet, P., Lavialle, M., Joffre, C., & Layé, S. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.11.001 · Cited by 128
“Studies using minocycline, a tetracycline derivative that inhibits microglial activation and cytokine production, show a link between brain cytokine production and depressive-like symptoms as well as spatial memory impairment (Choi et al., 2007; O’Connor et al., 2009).”
Disease-Induced Neuroinflammation and Depression
Benatti, C., M.C. Blom, J., Rigillo, G., Alboni, S., Zizzi, F., Torta, R., Brunello, N., & Tascedda, F. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160321104749 · Cited by 123
“[156] O'Connor JC, Lawson MA, André C, Moreau M, Lestage J, Castanon N, et al.”
Infectious disease-associated encephalopathies
Barbosa‐Silva, M. C., Lima, M. N., Battaglini, D., Robba, C., Pelosi, P. P., Rocco, P. R. M., & Maron‐Gutierrez, T. (2021) · Critical Care · doi:10.1186/s13054-021-03659-6 · Cited by 130
“These changes are in part induced by increased IDO activity [70], but also due to increased plasma levels of the aromatic aminoacid precursors of neurotransmitters, such as tyrosine, tryptophan, and phenylalanine, due to muscular proteolysis and liver failure [71].”
BackgroundThe role of the gut microbiome in the development of schizophrenia
Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.02.010 · Cited by 110
Lasselin, J., Lekander, M., Benson, S., Schedlowski, M., & Engler, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00869-2 · Cited by 114
A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase
Davies, Christmas, D., & Potokar, J. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s17573 · Cited by 119
“51 In addition, inhibition of IDO blocks the depressive behavior in these models 51,53 and administration of kynurenine induces depressive behavior in a dose-dependent manner.”
Liu, J., Buisman-Pijlman, F., & Hutchinson, M. R. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00309 · Cited by 119
“IDO further interferes with the synthesis of serotonin by catalyzing tryptophan, forming quinolinic acid and 3-hydroxy-kynurenine, which can further result in neurotoxicity (O’Connor et al., 2009).”
BackgroundCurcumin in Depression: Potential Mechanisms of Action and Current Evidence—A Narrative Review
Ramaholimihaso, T., Bouazzaoui, F., & Kaladjian, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.572533 · Cited by 135
Xie, Y., Wang, Y., Zhang, T., Ren, G., & Yang, Z. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-14 · Cited by 117
Khandaker, G. M., Zammit, S., Burgess, S., Lewis, G., & Jones, P. B. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.11.020 · Cited by 118
“Depression-like behaviour is observed in mice following experimental immune-activation with injection of lipopolysaccharide in peripheral circulation (O’Connor et al., 2009) or direct intracerebroventricular injection of IL-6 (Sukoff Rizzo et al.”
Cognitive deficits in interleukin-10-deficient mice after peripheral injection of lipopolysaccharide
Richwine, A. F., Sparkman, N. L., Dilger, R. N., Buchanan, J. B., & Johnson, R. W. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.02.020 · Cited by 111
Microbiota, immunoregulatory old friends and psychiatric disorders
Rook, G. A. W., Raison, C. L., & Lowry, C. A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4939-0897-4_15 · Cited by 117
Heisler, J. M., & O’Connor, J. C. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.022 · Cited by 113
Self-citationPotential roles of zinc in the pathophysiology and treatment of major depressive disorder
Swardfager, W., Herrmann, N., McIntyre, R. S., Mazereeuw, G., Goldberger, K., Cha, D. S., Schwartz, Y., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.018 · Cited by 116
André, C., O'Connor, J. C., Kelley, K. W., Lestage, J., Dantzer, R., & Castanon, N. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.011 · Cited by 111
“development of depressive-like behavior (O'Connor et al., 2008).”
BackgroundMethodSelf-citationSulakhiya, K., Kumar, P., Jangra, A., Dwivedi, S., Hazarika, N. K., Baruah, C. C., & Lahkar, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.049 · Cited by 122
Zhang, B., Wang, P., Hu, K., Li, L., Yu, X. L., Lu, Y., & Hong-sheng, C. (2019) · Molecules · doi:10.3390/molecules24112035 · Cited by 121
“Relevant studies have shown that intraperitoneal injection of LPS can lead to an acute inflammatory respons , causing d pression-like behavior and cognitive changes in mice [35].”
BackgroundResultInfluentialThe role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115
The role of the kynurenine pathway in suicidality in adolescent major depressive disorder
Bradley, K. A. L., Case, J. A. C., Khan, O., Ricart, T., Hanna, A., Alonso, C. M., & Gabbay, V. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.03.031 · Cited by 115
“, 2008), while peripheral inhibition of IDO blocked the central transcription of IDO in the brain and the development of depressive-like symptoms following immunological stimulation (O’Connor et al., 2009; Salazar et al., 2012).”
The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression
Rudzki, L., & Maes, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01961-y · Cited by 111
Zhang, J., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., Han, M., Wu, J., Ushida, Y., Suganuma, H., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.10.004 · Cited by 116
Comorbidity between epilepsy and depression: Role of hippocampal interleukin-1β
Mazarati, A. M., Pineda, E., Shin, D., Tio, D., Taylor, A. N., & Sankar, R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.001 · Cited by 113
“For example, inflammation induced both by lipopolysaccharide and by IL1β was accompanied by behavioral symptoms of depression (Dunn and Swiergiel, 2005; O'Connor et al., 2009; Yirmiya, 1996); lipopolysaccharide-induced depression was reversed by IL-1ra (Konsman et al., 2008).”
BackgroundTryptophan metabolites in depression: Modulation by gut microbiota
Lukić, I., Ivković, S., Mitić, M., & Adžić, M. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.987697 · Cited by 132
Parrott, J. M., Redus, L., & O’Connor, J. C. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0590-y · Cited by 112
Self-citationRinwa, P., & Kumar, A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.044 · Cited by 112
“Further, recent reports from O’Connor et al. (2009) revealed that minocycline produced antidepressant-like effects in an animal model of lipopolysaccharide-induced inflammation.”
ResultWoodling, N. S., Colas, D., Wang, Q., Minhas, P., Panchal, M., Liang, X., Mhatre, S. D., Brown, H., Ko, N., Zagol-Ikapitte, I., et al. (2016) · Brain · doi:10.1093/brain/aww117 · Cited by 107
“The supernatant fraction was collected for assay of kynurenine, and tryptophan by high performance liquid chromatography (HPLC) with electrochemical detection (Coulochem III detector; Dionex/Thermo Scientific) adapted from previous studies (Maneglier et al., 2004; O’Connor et al., 2009).”
MethodZunszain, P. A., Horowitz, M. A., Cattaneo, A., Lupi, M. M., & Pariante, C. M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.87 · Cited by 108
Mitochondrial transplantation attenuates lipopolysaccharide- induced depression-like behaviors
Wang, Y., Ni, J., Gao, C., Xie, L., Zhai, L., Cui, G., & Yin, X. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.04.010 · Cited by 113
Majidi, J., Kosari-Nasab, M., & Salari, A.-A. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.10.009 · Cited by 109
Laumet, G. O., Edralin, J. D., Chiang, A. C. A., Dantzer, R., Heijnen, C. J., & Kavelaars, A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0154-1 · Cited by 113
Self-citationHan, Y., Zhang, L., Wang, Q., Zhang, D.-D., Zhao, Q., Zhang, J., Xie, L., Liu, G., & You, Z. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.04.021 · Cited by 117
Filho, A. J. M. C., Lima, C. N. D. C., Vasconcelos, S. M. M., de Lucena, D. F., Maes, M. H. J., & Macêdo, D. S. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.035 · Cited by 116
“An important increase in IDO expression/activity and TRYCATs production was described in frontal-hippocampal regions of LPS-treated mice (André et al., 2008; O'Connor et al., 2009b).”
BackgroundInfluentialTryptophan depletion in depressed patients occurs independent of kynurenine pathway activation
Hughes, M. M., Carballedo, A., McLoughlin, D. M., Amico, F., Harkin, A., Frodl, T., & Connor, T. J. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.010 · Cited by 114
The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder
Liu, H., Ding, L., Zhang, H., Mellor, D., Wu, H., Zhao, D., Wu, C., Lin, Z., Yuan, J., & Peng, D. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00552 · Cited by 104
Neuroinflammation, Pain and Depression: An Overview of the Main Findings
Campos, A. C. P., Antunes, G. F., Matsumoto, M., Pagano, R. L., & Martinez, R. C. R. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.01825 · Cited by 114
Ge, L., Liu, L., Liu, H., Liu, S., Xue, H., Wang, X., Yuan, L., Wang, Z., & Liu, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.026 · Cited by 106
Role and possible mechanisms of Sirt1 in depression
Lu, G., Li, J., Zhang, H., Zhao, X., Yan, L.-J., & Yang, X. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8596903 · Cited by 106
Medina-Rodriguez, E. M., Lowell, J. A., Worthen, R. J., Syed, S. A., & Beurel, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00547 · Cited by 101
Inflammation in cancer and depression: a starring role for the kynurenine pathway
Sforzini, L., Nettis, M. A., Mondelli, V., & Pariante, C. M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05200-8 · Cited by 96
Molteni, R., Macchi, F., Zecchillo, C., Dell’Agli, M., Colombo, E., Calabrese, F., Guidotti, G., Racagni, G., & Riva, M. A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.008 · Cited by 112
Kang, A., Hao, H., Zheng, X., Liang, Y., Xie, Y., Xie, T., Dai, C., Zhao, Q., Wu, X., Xie, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-100 · Cited by 104
“8 mgkg) was selected because it could induce an acute sickness response in 4 h and reliable depression-like behavior at 24 h post-LPS challenge [13,31].”
BackgroundInfluentialZheng, X., An, K., Dai, C., Liang, Y. L., Xie, T., Xie, L. Y., Peng, Y., Wang, G., & Hao, H. (2012) · Analytical Chemistry · doi:10.1021/ac3025202 · Cited by 105
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
Kopra, E., Mondelli, V., Pariante, C., & Nikkheslat, N. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211026426 · Cited by 97
“In animal models, IDO activity has been found essential for inflammation-induced depressive symptoms (Lawson et al., 2013; O’Connor et al., 2009).”
BackgroundDelpech, J.-C., Madore, C., Joffre, C., Aubert, A., Kang, J. X., Nadjar, A., & Layé, S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.196 · Cited by 109
“Twenty-four hours after the treatment, mice have recovered from the sickness symptoms and present a normal locomotor activity, allowing us to investigate their working memory abilities (O’Connor et al, 2009).”
BackgroundMethodRoles of glutamate signaling in preclinical and/or mechanistic models of depression
Tokita, K., Yamaji, T., & Hashimoto, K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.016 · Cited by 111
“Lipopolysaccharide (LPS) increased the kynurenine/tryptophan ratio in both the plasma and brain, and minocycline attenuated all these LPS-induced increases (O'Connor et al., 2009).”
BackgroundChai, Y., Cai, Y., Fu, Y., Wang, Y., Zhang, Y., Zhang, X., Zhu, L., Miao, M., & Yan, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.812362 · Cited by 109
“Sal Ameliorates LPS-Induced Depression Sal Improves LPS-Induced Depression-Like Behaviors LPS can cause inflammation and is widely used to induce depression-like behaviors (O’Connor et al., 2009; Sekio and Seki, 2014).”
BackgroundGibney, S. M., Fagan, E. M., Waldron, A.-M., O‘Byrne, J., Connor, T. J., & Harkin, A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001673 · Cited by 101
“In addition, preclinical investigations indicate that IDO activation mediates the depressive-like behavioural effects of a systemic immune challenge (O’Connor et al., 2009).”
BackgroundLiu, L., Zhang, Q., Cai, Y., Sun, D., Xie, H., Wang, L., Yu, D., Li, X., Xiong, X., Xu, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11178 · Cited by 114
“Impaired hippocampal neurogenesis also occurs in some rodent and non-human primate models of depression such as repeat restraint stress, chronic unpredictable mild stress, social defeat stress, social isolation, and LPS or corticosterone administration [6-8].”
BackgroundMethodYang, L., Han, B., Zhang, Y., Bai, Y., Chao, J., Hu, G., & Yao, H. (2018) · Autophagy · doi:10.1080/15548627.2017.1414755 · Cited by 105
Pharmacological effects of berberine on mood disorders
Fan, J., Zhang, K., Jin, Y., Li, B., Gao, S., Zhu, J., & Cui, R. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13930 · Cited by 110
“tion of various neurotransmitters through activation of indoleamine 2,3‐dioxygenase (IDO).(55,56) Increased IDO activity may also”
BackgroundWang, N., Yu, H.-Y., Shen, X.-F., Gao, Z.-Q., Yang, C., Yang, J.-J., & Zhang, G.-F. (2015) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2015.1060281 · Cited by 100
Deyama, S., Ishikawa, Y., Yoshikawa, K., Shimoda, K., Ide, S., Satoh, M., & Minami, M. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx023 · Cited by 98
Vancassel, S., Capuron, L., & Castanon, N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00499 · Cited by 94
Self-citationCui, W., Ning, Y., Hong, W., Wang, J., Liu, Z., & Li, M. D. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1306-3 · Cited by 108
Ischemic stroke and intestinal flora: an insight into brain–gut axis
Hu, W., Kong, X., Wang, H., Li, Y., & Luo, Y. (2022) · European journal of medical research · doi:10.1186/s40001-022-00691-2 · Cited by 110
“A significant inflammatory response in the central nervous system was observed, suggesting inflammatory responses induced by bacterial products such as LPS can affect the central nervous system and promote the development of depression [106, 107].”
BackgroundMaciel, I. D. S., Silva, R. B. M., Morrone, F. B., Calixto, J. Β., & Campos, M. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077227 · Cited by 114
Kang, A., Xie, T., Zhu, D., Shan, J., Di, L., & Zheng, X. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b02386 · Cited by 101
Klyne, D. M., Barbe, M. F., van den Hoorn, W., & Hodges, P. W. (2018) · European Spine Journal · doi:10.1007/s00586-018-5490-7 · Cited by 109
The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration
Wang, Z., Zhang, Q., Yuan, L., Wang, S., Liu, L., Yang, X., Li, G., & Liu, D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.018 · Cited by 110
Pertl, M., Hevey, D., Boyle, N. T., Hughes, M. M., Collier, S., O’Dwyer, A.-M., Harkin, A., Kennedy, M. J., & Connor, T. J. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.07.177 · Cited by 104
“…studies have also reported associations between cytokine-stimulated kynurenine in the absence of trypto- phan depletion (Raison et al., 2010) and findings from animal studies suggest that peripheral administration of kynurenine alone can lead to depressive-like symptoms (O’Connor et al., 2009).”
Verdonk, F., Petit, A.-C., Abdel-Ahad, P., Vinckier, F., Jouvion, G., de Maricourt, P., De Medeiros, G. F., Danckaert, A., Van Steenwinckel, J., Blatzer, M., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.033 · Cited by 99
Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective
Hashimoto, K. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01182 · Cited by 98
Quak, J., Doornbos, B., Roest, A. M., Duivis, H. E., Vogelzangs, N., Nolen, W. A., Penninx, B. W. J. H., Kema, I. P., & de Jonge, P. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.013 · Cited by 98
Maes, M. H. J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.023 · Cited by 117
“In experimental animals, immune challenges were found to induce brain IDO (Lestage et al., 2002), which in turn mediates the depressive-like behavioral alterations following these challenges (O'Connor et al., 2009).”
Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders
Savitz, J. B. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_12 · Cited by 108
Caffeic acid attenuates lipopolysaccharide-induced sickness behaviour and neuroinflammation in mice
Mallik, S. B., Mudgal, J., Nampoothiri, M., Hall, S., Anoopkumar‐Dukie, S., Grant, G. D., Rao, C. M., & Arora, D. S. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.08.044 · Cited by 100
“Supportive evidence lies in the fact that patients undergoing cytokine therapy for cancer or viral diseases show depressed behaviour [6].”
Role of brain transmigrating neutrophils in depression-like behavior during systemic infection
Aguliar-Valles, A., Kim, J., Jung, S., Woodside, B., & Luheshi, G. N. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.137 · Cited by 97
Liu, T., Ma, Y., Zhang, R., Zhong, H., Wang, L., Zhao, J., Yang, L., & Fan, X. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5148-5 · Cited by 101
Toxoplasma gondii Immunoglobulin G Antibodies and Nonfatal Suicidal Self-Directed Violence
Zhang, Y., Träskman-Bendz, L., Janelidze, S., Langenberg, P., Saleh, A., Constantine, N., Okusaga, O., Bay-Richter, C., Brundin, L., & Postolache, T. T. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07532 · Cited by 97
Changes in behaviour and cytokine expression upon a peripheral immune challenge
Bay-Richter, C., Janelidze, S., Hallberg, L., & Brundin, L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.060 · Cited by 109
Robson, M. J., Quinlan, M. A., & Blakely, R. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00412 · Cited by 107
Citalopram reduces endotoxin-induced fatigue
Hannestad, J., DellaGioia, N., Ortiz, N., Pittman, B., & Bhagwagar, Z. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.013 · Cited by 95
The effects of apigenin on lipopolysaccharide-induced depressive-like behavior in mice
Li, R., Zhao, D., Qu, R., Fu, Q., & Ma, S. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.03.040 · Cited by 100
Kim, Y., Amidfar, M., & Won, E. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.008 · Cited by 102
Role of Inflammation in the Development of Neuropsychiatric Symptom Domains: Evidence and Mechanisms
Capuron, L., & Castanon, N. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_14 · Cited by 101
Self-citationRole of Inflammation in Depression and Treatment Implications
Felger, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_166 · Cited by 103
Minocycline in neurodegenerative and psychiatric diseases: An update
Romero‐Miguel, D., Lamanna‐Rama, N., Casquero‐Veiga, M., Gómez‐Rangel, V., Desco, M., & Soto‐Montenegro, M. L. (2021) · European Journal of Neurology · doi:10.1111/ene.14642 · Cited by 93
“Since the first preclinical study in 2007, several studies have shown that minocycline improves anxiety in different behavioral tests, especially forced swimming, tail suspension and open field tests [131-139], together with reduction of inflammation and/or inflammatory mediators [132,135,137,139-142] and recovery of…”
BackgroundXu, Y., Sheng, H., Tang, Z., Lu, J., & Ni, X. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.017 · Cited by 105
Fenn, A. M., Skendelas, J. P., Moussa, D. N., Muccigrosso, M. M., Popovich, P. G., Lifshitz, J., Eiferman, D. S., & Godbout, J. P. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2014.3514 · Cited by 96
Dang, R., Zhou, X., Tang, M., Xu, P., Gong, X., Liu, Y., Jiao, H., & Jiang, P. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1373-z · Cited by 93
NK cells promote neutrophil recruitment in the brain during sepsis-induced neuroinflammation
He, H., Geng, T., Chen, P., Wang, M., Hu, J., Kang, L., Song, W., & Tang, H. (2016) · Scientific Reports · doi:10.1038/srep27711 · Cited by 84
“Our data about LPS or CLP-induced depression-like behavior provided the evidence, and was consistent with previous reports 31,32 .”
Wang, Y., Gao, C., Gao, T., Zhao, L., Zhu, S., & Guo, L. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.02.004 · Cited by 90
Kim, S., Miller, B. J., Stefanek, M. E., & Miller, A. H. (2015) · Cancer · doi:10.1002/cncr.29302 · Cited by 91
Tomaz, V. D. S., Chaves Filho, A. J. M., Cordeiro, R. C., Jucá, P. M., Soares, M. V. R., Barroso, P. N., Cristino, L. M. F., Jiang, W., Teixeira, A. L., de Lucena, D. F., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.022 · Cited by 90
Wang, Y., Lawson, M. A., Dantzer, R., & Kelley, K. W. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.06.152 · Cited by 88
Self-citationChiappelli, J., Pocivavsek, A., Nugent, K. L., Notarangelo, F. M., Kochunov, P., Rowland, L. M., Schwarcz, R., & Hong, L. E. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.243 · Cited by 90
Serum kynurenic acid is reduced in affective psychosis
Wurfel, B. E., Drevets, W. C., Bliss, S. A., McMillin, J. R., Suzuki, H., Ford, B. N., Morris, H. M., Teague, T. K., Dantzer, R., & Savitz, J. B. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.88 · Cited by 92
Self-citationRéus, G. Z., Manosso, L. M., Quevedo, J., & Carvalho, A. F. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105425 · Cited by 103
Lipopolysaccharide Reduces Incentive Motivation While Boosting Preference for High Reward in Mice
Vichaya, E. G., Hunt, S. C., & Dantzer, R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.141 · Cited by 95
“However, most of these effects are observed rapidly after administration of LPS, whereas mice were tested 24 h after LPS in the present experiment, a time at which their food intake would be expected to have recovered (Dantzer et al, 2008; Frenois et al, 2007; O’Connor et al, 2009c).”
Self-citationMurray, C., Griffin, É. W., O’Loughlin, E., Lyons, A., Sherwin, E., Ahmed, S., Stevenson, N. J., Harkin, A., & Cunningham, C. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.04.009 · Cited by 89
Xie, W., Cai, L., Yu, Y., Gao, L., Xiao, L., He, Q., Ren, Z., & Liu, Y. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-41 · Cited by 92
“Proinflammatory cytokines, such as IL-1β, IL-6 and INF-γ, stimulate indoleamine 2,3-dioxygenase 1 (IDO1) in the brain [7-9].”
BackgroundMethodStress-Related Immune Markers in Depression: Implications for Treatment
Hughes, M. M., Connor, T. J., & Harkin, A. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw001 · Cited by 85
Atorvastatin prevents lipopolysaccharide-induced depressive-like behaviour in mice
Taniguti, E. H., Ferreira, Y. S., Stupp, I. J. V., Fraga-Junior, E. B., Doneda, D. L., Lopes, L., Rios-Santos, F., Lima, E., Buss, Z. S., Viola, G. G., et al. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.01.018 · Cited by 90
Sethi, R., Gómez‐Coronado, N., Walker, A. J., Robertson, O. D., Agustini, B., Berk, M., & Dodd, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00605 · Cited by 100
“Similarly, healthy individuals who received exogenous cytokines (IL-2, IFNα, and TNFα) also developed neuropsychiatric symptoms, including depression, mania, emotional dysregulation, cognitive impairment, and/or avolition (75).”
BackgroundArakawa, S., Shirayama, Y., Fujita, Y., Ishima, T., Horio, M., Muneoka, K. T., Iyo, M., & Hashimoto, K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.008 · Cited by 99
Slyepchenko, A., Maes, M., Köhler, C. A., Anderson, G., Quevedo, J., Alves, G. S., Berk, M., Fernandes, B. S., & Carvalho, A. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.002 · Cited by 89
Mayerhofer, R., Fröhlich, E. E., Reichmann, F., Farzi, A., Kogelnik, N., Fröhlich, E., Sattler, W., & Holzer, P. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.10.011 · Cited by 89
Doolin, K., Allers, K. A., Pleiner, S., Liesener, A., Farrell, C., Tozzi, L., O’Hanlon, E., Roddy, D., Frodl, T., Harkin, A., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.019 · Cited by 89
Lawson, M. A., Kelley, K. W., & Dantzer, R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.05.006 · Cited by 89
“Previous experiments with lipopolysaccharide or Bacillus Calmette–Guerin have repeatedly demonstrated that increased expression of cytokines induces sickness behavior and ultimately leads to depressive-like behavior in response to activation of IDO (O’Connor et al., 2009a,b,c).”
BackgroundResultSelf-citationDinel, A., André, C., Aubert, A., Ferreira, G., Layé, S., & Castanon, N. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.10.014 · Cited by 94
Self-citation
Metadata
- Authors
- O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Dantzer, R
- Venue
- Molecular Psychiatry
- Published
- 2008-01-15
- Volume
- 14
- Issue
- 5
- Pages
- 511-522
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- PMC
- PMC2683474
- OpenAlex
- W2050508296
- Cited by
- 1,278
- References
- 56
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 82 · 2023: 86 · 2022: 94 · 2021: 106 · 2020: 88 · 2019: 86 · 2018: 95 · 2017: 87 · 2016: 88 · 2015: 76 · 2014: 61 · 2013: 71 · 2012: 38
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG029573)
- National Institute of Mental Health (R01MH079829, R01MH071349, R01 MH-71349)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK059802, T32 DK59802-01)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- indoleamine 2,3-dioxygenase, lipopolysaccharide, depression-like behavior, kynurenine pathway, tryptophan catabolism, minocycline, 1-methyltryptophan, L-kynurenine, kynurenine/tryptophan ratio, serotonin turnover, inflammatory cytokines, comorbid depression
- MeSH terms
- Animals, Behavior, Animal, Chromatography, High Pressure Liquid, Cytokinins, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Gene Expression Regulation, Kynurenine, Lipopolysaccharides, Male, Mice, Inbred ICR, Minocycline, Motor Activity, Swimming, Time Factors, Tryptophan, Hindlimb Suspension, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.